NASDAQFinancialsBanks - RegionalSnapshot 2026-10-23
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
preserve strong balance sheet and moderate risk | The bank has a strong balance sheet and moderate risk. | Intact | significant deterioration in credit quality or capital ratios | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
maintain stable profit margins | It keeps profit margins steady near current levels. | Improving | profit margin declines more than 3 percentage points from current levels | Net margin: 19.41% FY2027-Q1; GAAP. Published target: maintain profit margin near current levels. Target percentage unit is not explicit. Source published Aug 12, 202619.411918 percent · calculatedSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2027-Q1 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: a0e6f274-6cb6-43f5-ac09-76065c809633. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
sustain revenue growth near 17% annually | A primary condition in Central Plains Bancshares Inc's published investment case. The stated target is >=16% YoY. | Intact | YoY revenue growth falls below 10% next year | Revenue growth: 16.79% FY2027-Q1; GAAP. Published target: >=16% YoY. Target period is not explicitly aligned with this observation. Source published Aug 12, 202616.790761 percent · calculatedSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2027-Q1 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: a0e6f274-6cb6-43f5-ac09-76065c809633. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
valuation remains reasonable versus peers | Its valuation is reasonable compared to peers. | Intact | PE ratio rises above 1.5 times peer median without growth improvement | P/E (TTM): 17.68x As of 2026-10-23; trailing twelve months. The target timing and basis require a separate assessment. Market data as of Oct 23, 202617.6756 ratio · calculatedLast status assessment Oct 24, 2026Measurement sourceconsolidated · TTM valuation Period ending Oct 23, 2026 Source: mart.stock_valuation_daily. Reference: CPBI:2026-10-23. Source status: canonical calculation. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Sep 25–Oct 24 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 12, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a financially sensitive business with a mixed, rather than clearly durable, multi-year setup. The long-term thesis is intact this month because recent performance remains in the top half of its industry, though risk has risen from moderate to elevated.
The valuation evidence is mixed: CPBI is described as cheap versus peers, while the model also shows a sizable premium versus peers and labels value expensive. The expectations gap is negative, and the evidence says the current pricing reflects weak execution quality without a broader stack of fragility factors.
Revenue and net income increased across the cited period, and management’s stated goal of sustaining growth and profitability is on track. Operating income has stayed positive, but cash from operations turned negative in 2027-Q1, leaving cash-flow execution mixed; the risk label also recently rose to elevated.
The near-term setup depends partly on interest rates and Financials sector conditions: the evidence says rate cuts could weigh on the sector, while strong results and higher guidance from HDB, IBN, and USB could support sector momentum. Misses or lower guidance from those bellwethers could weaken that support. Over the multi-year view, CPBI’s ability to sustain revenue growth, profitability, and positive cash generation also matters, while its stated annual repurchase goal remains under watch.
Over the next 1 to 3 years, the long-term thesis has support from improving revenue and net income, but elevated risk, uneven cash flow, and conflicting valuation signals leave meaningful execution and sector sensitivity. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.